2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Amy Tiersten: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer Durvalumab, Eribulin - HER2-Negative Metastatic Breast Cancer, Recurrent Ovarian Cancer | Phase 1 | Completed | Amy Tiersten | 9 | 2018-05-17 | 2020-08-05 |
| Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer Carboplatin, Everolimus - Breast Cancer | Phase 2 | Completed | Amy Tiersten | 64 | 2015-12-16 | 2025-02-19 |
Breast Neoplasms (2) · Ovarian Neoplasms (1)
Carboplatin (1) · Everolimus (1) · durvalumab (1) · eribulin (1)
United States (2)